Dimon is making his own bet on a digital coin that could transform the global payments landscape: JPM Coin.Financeread more
The Dow slipped from a record high set earlier in the day after President Trump cast doubt on the trade progress between China and the U.S.US Marketsread more
The U.S. and China have restarted their trade talks, but signs are showing a deal could be even harder to reach now.Marketsread more
Facebook's David Marcus said at a Senate hearing Tuesday that U.S. sanctions could be at risk without financial services innovation.Technologyread more
Goldman Sachs' transition from the bank of choice for millionaires to a more inclusive, consumer friendly shop isn't cheap.Financeread more
KeyCorp said in an 8-K filing the fraud involves a "business customer" and was discovered "on or about" July 9.Banksread more
The Trump administration "will take a look" after billionaire investor Peter Thiel said the FBI and CIA should see if Chinese intelligence has infiltrated Google.Technologyread more
On Monday, the first day of Amazon's 48-hour shopping extravaganza this year, retailers that make more than $1 billion in annual revenues saw a 64% increase in their digital...Retailread more
Builder confidence for single-family homes rose just one point to 65 in July, according to the National Association of Home Builders/Wells Fargo Housing Market Index (HMI)....Real Estateread more
Expectations for lower interest rates and less fear about tariffs sent investors back into the market and set up what could be a profitable run ahead.Marketsread more
Johnson & Johnson vowed to defend itself against lawsuits alleging the company fueled the opioid crisis and that its namesake talc-based baby powder caused ovarian cancer and...Health and Scienceread more
Canadian marijuana producer Cronos Group announced a cross-border partnership with California-based cannabis retailer MedMen on Monday, sending shares skyrocketing.
Cronos Group Shares closed up more than 11 percent on-the-day.
"We want to change the perception of cannabis worldwide, and bring it to the mainstream," Cronos Group CEO Mike Gorenstein said.
"It was really clear MedMen offered, by far, the best retail experience. We wanted to make sure we could bring that to Canada," he added.
MedMen Canada, as the joint venture will be called, is a new jointly managed company that will develop new, branded products and open stores across Canada.
The venture will leverage Cronos Group's Canadian expertise and product and MedMen's scalable branding, technology and retail experience.
"MedMen Canada will give us entry into an important emerging market for adult use and broaden our exposure worldwide," MedMen CEO and Co-founder Adam Bierman said in a statement.
"I think this is a milestone for the industry. You have an American and Canadian company with track records and resources to execute this venture — a meeting of giants," said MedMen spokesperson Daniel Yi.
"This speaks to the larger movement in mainstreaming marijuana and it shows that it is global movement," he added.
Furthermore, Gorenstein looks at the partnership with MedMen as one that could potentially prepare Cronos Group for a future in the U.S. market.
"This is the beginning – we look at this as a long term relationship," Gorenstein said.
MedMen, one of the largest cannabis retailers in California, has facilities in California, Nevada and New York. MedMen in January announced plans to list on the Canadian Securities Exchange as soon as April 15.
Cronos Group owns medical marijuana growing and distribution operations that serve Australian, Canadian, German and Israeli markets. In February, Cronos Group became the first "pure play" cannabis company to list on a major U.S. exchange.
Cronos Group shares are up 13.2 percent year-to-date and more than 300 percent in the past 12 months.